Los Angeles Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,189
Closed -$388K 1550
2020
Q1
$388K Sell
2,189
-2,920
-57% -$550K ﹤0.01% 983
2019
Q4
$977K Sell
5,109
-100
-2% -$18K ﹤0.01% 847
2019
Q3
$877K Sell
5,209
-48,808
-90% -$7.95M ﹤0.01% 841
2019
Q2
$9.04M Sell
54,017
-64,910
-55% -$8.99M 0.05% 327
2019
Q1
$17.4M Sell
118,927
-20,860
-15% -$3.02M 0.1% 219
2018
Q4
$18.7M Buy
139,787
+53,249
+62% +$8.73M 0.12% 189
2018
Q3
$16.5M Buy
86,538
+14,630
+20% +$2.69M 0.09% 254
2018
Q2
$12M Buy
71,908
+69,429
+2,801% +$11.1M 0.07% 318
2018
Q1
$417K Sell
2,479
-4,265
-63% -$715K ﹤0.01% 1086
2017
Q4
$1.1M Sell
6,744
-227,144
-97% -$40.8M 0.01% 834
2017
Q3
$47.9M Sell
233,888
-99,296
-30% -$23.1M 0.28% 99
2017
Q2
$81M Buy
333,184
+51,725
+18% +$12.2M 0.51% 35
2017
Q1
$67.2M Buy
281,459
+196,576
+232% +$45.8M 0.49% 39
2016
Q4
$17.8M Sell
84,883
-1,441
-2% -$299K 0.14% 195
2016
Q3
$19.9M Buy
86,324
+82,452
+2,129% +$20.1M 0.17% 172
2016
Q2
$895K Buy
3,872
+90
+2% +$20.8K 0.01% 734
2016
Q1
$1.01M Sell
3,782
-57,936
-94% -$16.6M 0.01% 620
2015
Q4
$19.3M Sell
61,718
-6,021
-9% -$1.79M 0.18% 154
2015
Q3
$18.4M Buy
67,739
+20,904
+45% +$6.42M 0.18% 157
2015
Q2
$14.2M Buy
46,835
+42,760
+1,049% +$12.8M 0.13% 215
2015
Q1
$1.21M Buy
4,075
+1,086
+36% +$310K 0.01% 700
2014
Q4
$769K Hold
2,989
0.01% 713
2014
Q3
$721K Buy
2,989
+1,006
+51% +$225K 0.01% 680
2014
Q2
$442K Sell
1,983
-55,960
-97% -$11.6M ﹤0.01% 922
2014
Q1
$11.9M Buy
57,943
+2,291
+4% +$454K 0.13% 207
2013
Q4
$9.35M Buy
55,652
+45,742
+462% +$7.15M 0.1% 245
2013
Q3
$1.43M Buy
9,910
+3,590
+57% +$478K 0.02% 562
2013
Q2
$798K Buy
+6,320
New +$716K 0.01% 736

Other funds holding AGN

Los Angeles Capital Management's AGN Position: Q2 2020 in Review

Los Angeles Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,189 shares — an estimated $388K sold.

Los Angeles Capital Management first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $81M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Los Angeles Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Los Angeles Capital Management sold 2,189 Allergan plc shares in Q2 2020, an estimated $388K.
  • Los Angeles Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Los Angeles Capital Management's Allergan plc position peaked at $81M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Los Angeles Capital Management's 13F filing for Q2 2020, filed 5 Aug 2020.